darolutamide
orion corp,bayer
['tps5111', 'arasec']
poster from neal shore at #asco22; the actively recruiting arasec trial (daro+adt vs adt in mhspc); study design, endpoints, &amp; inclusion/exclusion criteria. there is a qr code on the poster for those wishing to participate &amp; with suitable patients. poster 285a abst. tps5111
Independent and international experts in GenitoUrinary (GU) oncology. Part of https://t.co/QAbKORwRcf